Steroid Avoidance Versus Steroid Withdrawal After Simultaneous Pancreas‐Kidney Transplantation

D. Cantarovich,G. Karam,M. Hourmant,J. Dantal,G. Blancho,M. Giral,J. Soulillou
DOI: https://doi.org/10.1111/j.1600-6143.2005.00816.x
IF: 9.369
2005-06-01
American Journal of Transplantation
Abstract:Two steroid‐sparing immunosuppressive regimens were prospectively compared in recipients of simultaneous pancreas‐kidney transplants, one did not include steroids at all and the other included steroids for the first 3 months following transplantation. All patients received rabbit anti‐thymocyte globulin, mycophenolate mofetil (MMF) and cyclosporine. Fifty patients were randomised in an open‐label, single center and prospective study. The incidence of biopsy‐proven acute rejection during the first 12 months after transplantation was the primary endpoint of the study.
What problem does this paper attempt to address?